Sara Delfanti

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial

Quincy S. Chu, Laurent Greillier, Wei Tu et al. · The Lancet · 2023 · 101 citations

Medicine, Oncology, Pharmacology +15

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study

David J. Pinato, Daniela Ferrante, Georgina Hanbury et al. · The Lancet Oncology · 2022 · 80 citations · Full text

Medicine, Infectious Diseases, Oncology +16

Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, multicentre, single-arm study

Viviana Vitolo, Lorenzo Cobianchi, Silvia Brugnatelli et al. · BMC Cancer · 2019 · 40 citations · Full text

Medicine, Oncology, Surgery +17

Systemic Chemotherapy for Advanced Rare Pancreatic Histotype Tumors

Oronzo Brunetti, Giuseppe Aprile, Paolo Marchetti et al. · Pancreas · 2018 · 34 citations · Full text

Medicine, Oncology, Pathology +17

Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trial

Chiara Cremolini, Federica Marmorino, Francesca Bergamo et al. · European Journal of Cancer · 2019 · 34 citations

Medicine, Oncology, Pharmacotherapy +14